Another iron chelator, deferiprone decreased brain iron levels and sarkosyl-insoluble tau and this was accompanied by improvements in anxiety-like behavior in a tauopathy model [rTg(tauP301L)4,510] (Rao et al., 2020). This evidence concerns the gene MAPT and tauopathy.